Weight Loss Drug FDA
Links shared publicly online about this topic
Weight-Loss Drug: FDA Panel Recommends Approval For Contrave
huffingtonpost.com — “A Food and Drug Administration panel on Tuesday recommended that the agency approve Orexigen Therapeutics Inc.'s weight loss drug Contrave, making it the first in group of competitors to get a positive nod from experts. The panel of experts voted 13 to 7 for Contrave's approval, and 11 to 8, with an abstention, that additional studies be conducted on heart risks.” View full resource at huffingtonpost.com
Most Recently Shared on December 8, 2010 at 10:22 pm By:
FDA Panel Backs New Weight Loss Drug http://www.huffingtonpost.com/2010/12/08/weightloss-drug-fda-panel_n_793833.html
Weight-Loss Drug: FDA Recommends Weight Loss Drug Contrave | ThirdAge
thirdage.com — “Weight-Loss drugs rarely get a ringing endorsement from the FDA, but this week - a formal recommendation from the FDA was announced for theweight-loss drug Contrave.A Food and Drug Administration panel on Tuesday recommended that the agency approve” View full resource at thirdage.com
Most Recently Shared on December 9, 2010 at 1:19 pm By:
Weight-Loss Drug: FDA Recommends Weight Loss Drug Contrave http://bit.ly/fcUMhu
FDA Reconsiders Weight Loss Drug Qnexa
webmd.com — “The FDA is once again considering approval of an experimental weight loss drug it rejected a year ago over concerns about potential heart problems and birth defects in babies born to women who take it.” View full resource at webmd.com
Most Recently Shared on November 9, 2011 at 10:27 pm By:
FDA Reconsiders Weight Loss Drug Qnexa - The FDA is once again considering approval of an experimental weight loss d... http://t.co/VFfCSvqm
FDA to Review First of 3 New Weight Loss Drugs.
intelihealth.com — “FDA to Review First of 3 New Weight Loss Drugs.” View full resource at intelihealth.com
Most Recently Shared on July 14, 2010 at 2:50 pm By:
FDA to Review First of 3 New Weight Loss Drugs. http://www.intelihealth.com/IH/ihtIH/WSIHW000/333/21142/1371017.html
FDA Panel Says 'No' to Weight Loss Drug Qnexa
webmd.com — “An FDA advisory panel voted against approval of the weight loss drug Qnexa because of potential side effects.” View full resource at webmd.com
Most Recently Shared on July 15, 2010 at 10:59 pm By:
webMD: FDA Panel Says 'No' to Weight Loss Drug Qnexa http://bit.ly/cyzxHi Full http://bit.ly/c0LmiA
FDA Won't Approve Weight Loss Drug Contrave
webmd.com — “The FDA has for now decided not to approve the weight loss drug Contrave.” View full resource at webmd.com
Most Recently Shared on February 1, 2011 at 10:40 pm By:
The FDA has for now decided not to approve the weight loss drug Contrave. http://bit.ly/ezOJqS
Weight loss: FDA declines to approve weight-loss drug Lorcaserin - latimes.com
latimes.com — “The FDA says it won't OK the weight-loss drug Lorcaserin at this time, citing concerns about its effectiveness and cancers that occurred during clinical trials.” View full resource at latimes.com
Most Recently Shared on October 24, 2010 at 4:25 am By:
Obesity Crisis In The Spotlight As FDA Reviews Weight Loss Drugs
medicalnewstoday.com — “The Washington Post explores the obesity epidemic by reportin” View full resource at medicalnewstoday.com
Most Recently Shared on July 13, 2010 at 3:06 pm By:
Obesity Crisis In The Spotlight As FDA Reviews Weight Loss Drugs http://mnt.to/3G2K #weightloss
Weight Loss Drugs and Supplements - Dangerous Weight Loss Drugs and Supplements
patients.about.com — “The FDA has determined that at least 28 "natural" or "herbal" weight loss drugs and supplements are contaminated with dangerous ingredients which may lead to debilitation or death. Find the most recent list of dangerous weight loss drugs and learn why they may harm you.” View full resource at patients.about.com
Most Recently Shared on December 29, 2008 at 9:48 pm By:
Weight Loss Resolution for 2009? FDA Cites Contaminated (Counterfeit?) Weight Loss Drugs http://piurl.com/_KD
Weight loss: FDA won't OK prescription weight-loss drug Qnexa - latimes.com
latimes.com — “The FDA has asked the drug's developer, Vivus, to provide data about whether Qnexa can cause birth defects and to quantify what that risk might be. Vivus expects to be able to address the agency's concerns.” View full resource at latimes.com
Most Recently Shared on November 2, 2010 at 4:15 pm By:
FDA won't OK prescription weight-loss drug Qnexa http://lat.ms/cI2GYm
Weight Loss Drugs Dubbed Fraudulent and Illegal by FDA | ThirdAge
thirdage.com — “Weight loss drugs that contain hCG are fraudulent and illegal according to the the US Food and Drug Administration. The products are a homeopathic drug sold in pellets, drops and sprays. They can be found in products sold in drugstore, General Nutrition” View full resource at thirdage.com
Most Recently Shared on January 25, 2011 at 4:20 pm By:
Weight Loss Drugs Dubbed Fraudulent and Illegal by FDA http://bit.ly/gQiNPI
Orexigen Weight Loss Drug On Track For FDA Approval | ThirdAge
thirdage.com — “Orexigen Therapeutics, Inc. said Tuesday that the Food and Drug Administration has agreed to a study to revive the company's previously-rejected weight loss drug Contrave.” View full resource at thirdage.com
Most Recently Shared on September 20, 2011 at 11:34 pm By:
Orexigen Weight Loss Drug On Track For FDA Approval http://t.co/xOhfevyd
Orexigen Weight Loss Drug Rejected by FDA | ThirdAge
thirdage.com — “Orexigen Therapeutics Inc., a small California-based company, suffered a major plunge as shares fell as much as seventy-three percent in early trading. Orexigen stock lost 6.57 points to $2.50 dollars. The steep decrease came after the U.S. Food and Drug” View full resource at thirdage.com
Most Recently Shared on February 1, 2011 at 7:06 pm By:
Weight loss: FDA declines to approve weight-loss drug Lorcaserin - latimes.com
latimes.com — “The FDA says it won't OK the weight-loss drug Lorcaserin at this time, citing concerns about its effectiveness and cancers that occurred during clinical trials.” View full resource at latimes.com
Most Recently Shared on October 30, 2010 at 1:03 pm By:
Weight loss: FDA won't OK prescription weight-loss drug Qnexa - latimes.com
latimes.com — “The FDA has asked the drug's developer, Vivus, to provide data about whether Qnexa can cause birth defects and to quantify what that risk might be. Vivus expects to be able to address the agency's concerns.” View full resource at latimes.com
Most Recently Shared on October 30, 2010 at 12:19 am By:
FDA won't OK prescription weight-loss drug Qnexa http://lat.ms/cs1HkN
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
James Beckerman, MD
WebMD heart expert, cardiologist, author of The Flex Diet. Make it your idea in the first place. Find your problem first. And always look up.
-
ThirdAge.com
A boomer's guide to a life of health, happiness, passion & purpose.
-
Dr. M Salim Ismail MD
Regenerative & Integrative Health Physician. Medical Director of Desana WholeHealth, World Leader in Health Technologies & Regeneration.
Advertisement

